Fibronectin Protects from Excessive Liver Fibrosis by Modulating the Availability of and Responsiveness of Stellate Cells to Active TGF-β

• Nina Kawelke,

  Affiliations Translational Medicine, Max-Planck Institute for Biochemistry, Martinsried, Germany, Institute for Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Matthaeus Vasel,

  Affiliations Translational Medicine, Max-Planck Institute for Biochemistry, Martinsried, Germany, Institute for Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Carla Sens,

  Affiliations Translational Medicine, Max-Planck Institute for Biochemistry, Martinsried, Germany, Institute for Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Anja von Au,

  Affiliations Translational Medicine, Max-Planck Institute for Biochemistry, Martinsried, Germany, Institute for Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Steven Dooley,

  Affiliation Department of Medicine II, University of Heidelberg at Mannheim, Mannheim, Germany

  ⨯
• Inaam A. Nakchbandi

  * E-mail: inaam.nakchbandi@urz.uni-heidelberg.de

  Affiliations Translational Medicine, Max-Planck Institute for Biochemistry, Martinsried, Germany, Institute for Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯